Karman Stock Plummets -27% With 5-Day Losing Streak
Karman (KRMN) – a provider of mission-critical missile, defense, and space systems. – hit a 5-day losing streak, with cumulative losses over this period amounting to -27%. The company’s market cap has crashed by about $3.6 Bil over the last 5 days and currently stands at $9.9 Bil.
Sustained weakness can be more than noise. It often signals shifting sentiment or deeper concerns. A multi-day losing streak may warn of further downside, or present an opportunity to buy if fundamentals are intact.
But here is the interesting part. You are reading about this -27% move after it happened. The market has already priced in the news. To manage individual stock risk before the headlines, you need predictive signals, not notifications. High Quality Portfolio has a risk model designed to manage stock-specific drawdowns better.
Returns vs S&P 500
- Salesforce Stock Can Sink, Here Is How
- Is Philip Morris International Stock Undervalued Stock Or Value Trap?
- Is LLY Stock Setup For A Rerating?
- Is Tenet Healthcare Stock an Under-Analyzed Capital Compounder Opportunity?
- 5 Catalysts to Monitor Over In The Next 2 Quarters For LLY Stock
- Could Accenture Stock’s Cash Flow Spark the Next Rally?
The following table summarizes the return for KRMN stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | KRMN | S&P 500 |
|---|---|---|
| 1D | -11.0% | -0.4% |
| 5D (Current Streak) | -26.9% | -3.6% |
| 1M (21D) | -15.1% | -7.8% |
| 3M (63D) | -3.5% | -8.5% |
| YTD 2026 | 2.3% | -7.3% |
| 2025 | 16.4% | |
| 2024 | 23.3% | |
| 2023 | 24.2% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 33 S&P constituents with 3 days or more of consecutive gains and 142 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 16 | 105 |
| 4D | 0 | 26 |
| 5D | 7 | 10 |
| 6D | 10 | 0 |
| 7D or more | 0 | 1 |
| Total >=3 D | 33 | 142 |
Key Financials for Karman (KRMN)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $280.7 Mil | $345.3 Mil |
| Operating Income | $48.5 Mil | $63.6 Mil |
| Net Income | $4.4 Mil | $12.7 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $115.1 Mil | $121.8 Mil |
| Operating Income | $20.1 Mil | $21.8 Mil |
| Net Income | $6.8 Mil | $7.6 Mil |
The losing streak KRMN stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.